A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

Study to Investigate the Efficacy of Symbicort® SMART.

NCT00839800 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation

NCT01232335 ·Status: COMPLETED

Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma

NCT00573222 ·Status: COMPLETED

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

NCT00784953 ·Status: COMPLETED

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 ·Status: TERMINATED ·Phase: PHASE3

Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

NCT00939341 ·Status: COMPLETED ·Phase: PHASE4

Symbicort Turbuhaler 30/60 Clinical Experience Investigation

NCT01232348 ·Status: COMPLETED

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

NCT00937066 ·Status: COMPLETED

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

NCT00235911 ·Status: COMPLETED ·Phase: PHASE3

Prevention of Asthma Relapse After Discharge From Emergency

NCT00326053 ·Status: COMPLETED ·Phase: PHASE3

A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

NCT00532922 ·Status: COMPLETED

Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

NCT00524641 ·Status: COMPLETED

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

NCT00812357 ·Status: COMPLETED

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

NCT00837967 ·Status: COMPLETED ·Phase: PHASE3

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

NCT00884689 ·Status: COMPLETED

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 ·Status: COMPLETED

Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers

NCT01668121 ·Status: COMPLETED ·Phase: PHASE1

NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART

NCT00785733 ·Status: COMPLETED

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.

NCT02149199 ·Status: COMPLETED ·Phase: PHASE3

Effect of Symbicort on GR Localisation in Asthma

NCT00159263 ·Status: COMPLETED ·Phase: NA

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

Titratable Dosing in Moderate to Severe Asthmatics

NCT00651768 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics.

NCT00858286 ·Status: COMPLETED ·Phase: PHASE4

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

NCT00576316 ·Status: COMPLETED ·Phase: PHASE4